Abstract: The present invention relates to a topical nano-dispersion composition comprising one or more non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, local anesthetics, analgesics, gabapentinoids, alone or combinations thereof. The composition includes a dispersed phase containing drug(s), lipids, surfactants, amphiphilic penetration enhancers, and solvents, along with an aqueous phase. The nano-dispersion has particle sizes below 300 nm with unimodal particle size distribution, offering enhanced skin permeability and controlled drug release for up to 24 hours. The composition can be formulated into gels, creams, patches, lotions, liquid, or sprays, providing improved patient compliance through non-greasy, fast-absorbing formulations with extended shelf life.
| # | Name | Date |
|---|---|---|
| 1 | 202647035008-STATEMENT OF UNDERTAKING (FORM 3) [23-03-2026(online)].pdf | 2026-03-23 |
| 2 | 202647035008-FORM FOR SMALL ENTITY(FORM-28) [23-03-2026(online)].pdf | 2026-03-23 |
| 3 | 202647035008-FORM 18 [23-03-2026(online)].pdf | 2026-03-23 |
| 4 | 202647035008-FORM 1 [23-03-2026(online)].pdf | 2026-03-23 |
| 5 | 202647035008-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [23-03-2026(online)].pdf | 2026-03-23 |
| 6 | 202647035008-DRAWINGS [23-03-2026(online)].pdf | 2026-03-23 |
| 7 | 202647035008-DECLARATION OF INVENTORSHIP (FORM 5) [23-03-2026(online)].pdf | 2026-03-23 |
| 8 | 202647035008-COMPLETE SPECIFICATION [23-03-2026(online)].pdf | 2026-03-23 |
| 9 | 202647035008-PATENT_APPLICATION_PUBLICATION.pdf | 2026-04-06 |
| 10 | 202647035008-Proof of Right [15-06-2026(online)].pdf | 2026-06-15 |
| 11 | 202647035008-FORM-26 [15-06-2026(online)].pdf | 2026-06-15 |